Similar Articles
Different Guillain-Barré Syndrome Variants Associated with COVID-19: Report of 4 Clinical Cases
Zeynep Ünlütürk, Çağatay Hilmi Öncel, Barış Haytı, Çağdaş Erdoğan
DOI: 10.4274/tnd.2021.86094
Twelfth Cranial Nerve Involvement in Guillain-Barre Syndrome: A Case Report
Gizem Çifter, Gholamreza Hoseinzadeh, Elif Simin Issı, Demet İlhan Algın, Oğuz Osman Erdinç
DOI: 10.4274/tnd.2020.60948
Factors Associated with Prognosis in Patients with Guillain-Barré Syndrome
Mustafa Çetiner, Murat Seyit, Gönül Akdağ, Hayri Demirbaş, Özge Temel, Sibel Canbaz Kabay
DOI: 10.4274/tnd.2019.34445
The Importance of Consultation Neurology: A Patient with Anti-Glutamic Acid Decarboxylase Antibody-Associated Cerebellar Ataxia Recognized in the Psychiatry Inpatient Clinic
Zeynep Ezgi Balçık, Sezin Alpaydın Baslo, Elif Söylemez, Betül Güveli, Dilek Ataklı
DOI: 10.4274/tnd.37973
Differential Diagnosis Approach to Bilateral Peripheral Facial Paralysis: A Case Report
Nihan Hande Akçakaya, Meltem Hale Alpsan Gökmen, Yeşim Gülşen Parman, Feza Deymeer, Piraye Oflazer
DOI: 10.4274/tnd.02212
A Rare Guillain Barre Syndrome Variant: Facial Diplegia Paresthesia
Emel Oguz Akarsu, Destina Yalçın, Reyhan Sürmeli, Ahmet Demir, Gülin Sünter, Yunus Diler
DOI: 10.4274/tnd.70456
Side Effects of Intravenous Immunoglobulin Treatment in Neurological Disorders
Buket Oflazoğlu, Fatma Öztürk, Hatice Kayaalp Açık, Çağatay Öncel, Ülker Anadol, Hulki Forta
Immunoglobulin Treatment and Electrophysiological Findings in -Guillain-Barrè Syndrome
Münevver ÇELİK, Buket OFLAZOĞLU, Hulki FORTA
Guillain-Barré Syndrome with Bilateral Peripheral Facial Nerve Paralysis After COVID-19 Infection
Özgül Ocak
DOI: 10.4274/tnd.2021.78095
Guillain-Barré Syndrome and COVID-19 Vaccines: A Comment
Joob Beuy, Viroj Wiwanitkit
DOI: 10.4274/tnd.2021.47048